Since its inception, NovoPath has played a crucial role in large clinical trials which have at their heart, precision medicine. Dr Max Robinson leads on this for NovoPath and he is Co-Chair of SPIRIT an initiative run by NCRI CM Path.
We have contributed to a myriad of trials but of particular note are those in the area of diagnosis and prognostication in oral dysplasia and head and neck cancers with involvement for example in PEARL, ComPARE, SAVER, MOSES, PATHOS phase III, PEDICTR2 trials.